Giovanni Martinelli

发表

A novel methodology based on clustering techniques for automatic processing of MV feeder daily load patterns

Regina Lamedica, A. Prudenzi, L. Santolamazza, 2000, 2000 Power Engineering Society Summer Meeting (Cat. No.00CH37134).

Il Test di Coombs Diretto, test all’antiglobulina Diretto positivo e AEA-2

Giovanni Martinelli, 2013 .

LSP Attribute in ERO

Cyril Margaria, Ben Wright, Giovanni Martinelli, 2013 .

Tromometric Measurements as a Tool for Crustal Deformation Monitoring

Dario Albarello, Giovanni Martinelli, Graziano Ferrari, 2000 .

A SNMP MIB to manage GMPLS TED with WSON specific support

Dharini Hiremagalur, Gabriele Galimberti, Gert Grammel, 2012 .

Information Encoding for WSON with Impairments Validation

Gabriele Galimberti, Fatai Zhang, Giovanni Martinelli, 2019 .

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Francisco Cervantes, Ryuzo Ohno, Richard E. Clark, 2013, Blood.

Network integration of multi-tumour omics data suggests novel targeting strategies

Giulia Menichetti, Gastone Castellani, Daniel Remondini, 2017, bioRxiv.

Supplementary Table S2

A. Boattini, Simona Soverini, Giovanni Martinelli, 2012 .

The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD)

Gastone Castellani, Daniel Remondini, Giovanni Martinelli, 2015, Oncotarget.

A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2

Jennifer N. Dines, Massimiliano Mazza, Giovanni Martinelli, 2020, Research square.

BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet.

Simona Soverini, Giovanni Martinelli, Thomas Ernst, 2011, Blood.

Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia

Giovanni Martinelli, Ilaria Iacobucci, Cristina Papayannidis, 2016, Oncotarget.

Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors.

Giovanni Martinelli, Giancarlo Pruneri, G. Pruneri, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Relationship between genome and epigenome - challenges and requirements for future research

Magnus Rattray, Xavier Estivill, Ana Conesa, 2014, BMC Genomics.

A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia.

Sante Tura, Giovanni Martinelli, Giuseppe Saglio, 2002, Blood.

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

Francisco Cervantes, Simona Soverini, Giovanni Martinelli, 2013, Blood.

A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.

Serge Leyvraz, Giovanni Martinelli, S. Peters, 2008, Journal of the National Cancer Institute.

Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

Giovanni Martinelli, Stefano Luminari, Luigi Rigacci, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Supplementary Data 1

A. Boattini, Simona Soverini, Giovanni Martinelli, 2013 .

Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia.

Giovanni Martinelli, Nicola Esposito, Giuseppe Saglio, 2014, Leukemia research.

Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma

Francesco Bertoni, Ivo Kwee, Giovanni Martinelli, 2006, British journal of haematology.

The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations.

Giovanni Martinelli, Pier Giuseppe Pelicci, Ilaria Iacobucci, 2015, Blood.

Prevention of High-Dose Chemotherapy-Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition

Giovanni Martinelli, Fabrizio Veglia, Carlo M. Cipolla, 2006, Circulation.

Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.

Giovanni Martinelli, Arnon Nagler, Giovanna Rege-Cambrin, 2009, Blood.

Minor increases in plasma troponin I predict decreased left ventricular ejection fraction after high-dose chemotherapy.

Giovanni Martinelli, G. Martinelli, C. Cipolla, 2003, Clinical chemistry.

IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells.

Giovanni Martinelli, Veronica Huber, Licia Rivoltini, 2004, Blood.

International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

Giovanni Martinelli, Michael Doubek, Aaron Katz, 2016, Haematologica.

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.

Simona Soverini, Giovanni Martinelli, Susan Branford, 2006, Blood.

CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma.

Giovanni Martinelli, Giancarlo Pruneri, G. Pruneri, 2002, Cancer research.